• Psoriasis Treatment Market Segment Analysis

    By drug class, the global market has been categorized into TNF inhibitors, Interleukin inhibitors, Vitamin D analogs, Corticosteroids, and others. Tumour Necrosis Factor Inhibitors is further categorized as Adalimumab, Infliximab, Etanercept. Vitamin D Analogues is segmented into Calcitriol, Calcipotriol, Tacalcitol. The Interleukin inhibitors segment is projected to lead the global market during the forecast period.
    Psoriasis Treatment Market Segment Analysis By drug class, the global market has been categorized into TNF inhibitors, Interleukin inhibitors, Vitamin D analogs, Corticosteroids, and others. Tumour Necrosis Factor Inhibitors is further categorized as Adalimumab, Infliximab, Etanercept. Vitamin D Analogues is segmented into Calcitriol, Calcipotriol, Tacalcitol. The Interleukin inhibitors segment is projected to lead the global market during the forecast period.
    WWW.MAXIMIZEMARKETRESEARCH.COM
    Psoriasis Treatment Market - Global Industry Analysis and Forecast (2023 - 2029)
    Psoriasis Treatment Market size is expected to grow at a CAGR of 9.3% and the market size is expected to reach nearly US$ 48.99 Bn. by 2029.
    0 Comments 0 Shares
  • Comments Shares
  • Comments Shares